Figure 1From: Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study HOMA-β cell function (%) levels versus vitamin D (nmol/L) in male and female Saudi T2DM subjects who were on daily vitamin D3 (2000 IU) supplementation for 18 months in successive follow-up visits; significance at P < 0.05. Back to article page